Amgen Quarterly Profit Beats Wall Street View on New Product Sales

By REUTERS
NYT
Amgen Inc on Thursday reported a better-than-expected second quarter profit and raised its full-year forecast, as growth of newer drugs like cholesterol fighter Repatha and osteoporosis drug Prolia offset weakness in older products.
Published date: July 26, 2018 at 11:45PM
Reuters
New York Times article